A concerted genomic and proteomic approach to understand the early stages of prostate carcinogenesis
Cancer of the prostate (CaP) is the most common cancer in men and the second leading cause of death from cancer. To improve survival rates, an understanding of the molecular events that govern this disease is critical. We approach this goal through a concerted effort to identify the critical, early...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2009
|
| Online Access: | http://hdl.handle.net/2429/13967 |